KAHRAMAN, D. C. And ATALAY, R. 2017. Differential alteration of IL-8 in response to Sorafenib and PI3K/Akt/mTOR inhibitors in liver cancer cells and in liver cancer stem cells. AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics , (Philadelphia, United States Of America).

KAHRAMAN, D. C., & ATALAY, R., (2017). Differential alteration of IL-8 in response to Sorafenib and PI3K/Akt/mTOR inhibitors in liver cancer cells and in liver cancer stem cells . AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Philadelphia, United States Of America

KAHRAMAN, DENİZ, And RENGÜL ATALAY. "Differential alteration of IL-8 in response to Sorafenib and PI3K/Akt/mTOR inhibitors in liver cancer cells and in liver cancer stem cells," AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Philadelphia, United States Of America, 2017

KAHRAMAN, DENİZ C. And ATALAY, RENGÜL. "Differential alteration of IL-8 in response to Sorafenib and PI3K/Akt/mTOR inhibitors in liver cancer cells and in liver cancer stem cells." AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics , Philadelphia, United States Of America, 2017

KAHRAMAN, D. C. And ATALAY, R. (2017) . "Differential alteration of IL-8 in response to Sorafenib and PI3K/Akt/mTOR inhibitors in liver cancer cells and in liver cancer stem cells." AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics , Philadelphia, United States Of America.

@conferencepaper{conferencepaper, author={DENİZ CANSEN KAHRAMAN And author={RENGÜL ATALAY}, title={Differential alteration of IL-8 in response to Sorafenib and PI3K/Akt/mTOR inhibitors in liver cancer cells and in liver cancer stem cells}, congress name={AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics}, city={Philadelphia}, country={United States Of America}, year={2017}}